The role of public education in the early detection of melanoma

References

• Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969–1999. JAMA288, 1719–1720 (2002).
   PubMed Web of Science ®Google Scholar
• IARC Cancerbase. Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Press, Lyon, France (2001).
   Google Scholar
• Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996. Int. J. Cancer92, 457–462 (2001).
   PubMed Web of Science ®Google Scholar
• Ries LAG, Eisner MP, Kosary CL et al. SEER Cancer Statistics Review, 1975–2002. National Cancer Institute, NIH, Bethesda, MD, USA (2003).
   Google Scholar
• De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int. J. Cancer107, 119–126 (2003).
   PubMed Web of Science ®Google Scholar
• Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969–1993. Int. J. Epidemiol.29, 416–423 (2000).
   PubMed Web of Science ®Google Scholar
• MacKie RM, Bray CA, Hole DJ et al. incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet360, 587–591 (2002).
   PubMed Web of Science ®Google Scholar
• Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res.14, 301–309 (2004).
   PubMedGoogle Scholar
• Lindholm C, Andersson R, Dufmats M et al. Invasive cutaneous malignant melanoma in Sweden, 1990–1999. A prospective, population-based study of survival and prognostic factors. Cancer101, 2067–2078 (2004).
   PubMedGoogle Scholar
• Demierre MF. Thin melanomas and regression, thick melanomas and older men: prognostic implications and perspectives on secondary prevention. Arch. Dermatol.138, 678–682 (2002).
   PubMedGoogle Scholar
• Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northerm California and national trends 1990–2000. J. Invest. Dermatol.125, 685–691 (2005).
   PubMed Web of Science ®Google Scholar
• Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene22, 3042–3052 (2003).
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Doré JF. Sunscreen use and increased duration of intentional sun exposure: still a burning issue. Int. J. Cancer121, 1–5 (2007).
   PubMed Web of Science ®Google Scholar
• Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev.14, 562–566 (2005).
   PubMed Web of Science ®Google Scholar
• Grant WB. Solar ultraviolet irradiance and cancer incidence and mortality. Adv. Exp. Med. Biol.624, 16–30 (2008).
   PubMed Web of Science ®Google Scholar
• Halpern AC, Lieb JA. Early melanoma diagnosis: a success story that leaves room for improvement. Curr. Opin. Oncol.19, 109–115 (2007).
   PubMedGoogle Scholar
• Lasithiotakis KG, Leiter U, Gorkievicz R et al. The incidence and mortality of cutaneous melanoma in Southerm Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer107, 1331–1339 (2006).
   PubMed Web of Science ®Google Scholar
• Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front. Biosci.11, 1244–1254 (2006).
   PubMed Web of Science ®Google Scholar
• Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer89, 1269–1278 (2000).
   PubMed Web of Science ®Google Scholar
• Crocetti E, Carli P. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur. J. Dermatol.13, 72–75 (2003).
   PubMedGoogle Scholar
• Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection and trends for melanoma: current status (2000–2006) and future directions. J. Am. Acad. Dermatol.57, 555–572 (2007).
   PubMedGoogle Scholar
• Stratigos AJ, Katsambas AD. The value of screening in melanoma. Clin. Dermatol.27, 10–25 (2009).
   PubMedGoogle Scholar
• Koh HK, Norton LA, Geller AC et al. Evaluation of the American Academy of Dermatology’s national skin cancer detection and screening program. J. Am. Acad. Dermatol.34, 971–978 (1996).
   PubMed Web of Science ®Google Scholar
• Richard MA, Grob JJ, Avril MF et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch. Dermatol.135, 269–274 (1999).
   PubMedGoogle Scholar
• Melia J, Harland C, Moss S, Eiser JR, Pendry L. Feasibility of targeted early det- ection for melanoma: a population-based screening study. Br. J. Cancer82, 1605–1609 (2000).
   PubMed Web of Science ®Google Scholar
• Jackson A, Wilkinson C, Pill R. Moles and melanomas – who’s at risk, who knows, and who cares? A strategy to inform those at high risk. Br. J. Gen. Pract.49, 199–203 (1999).
   PubMedGoogle Scholar
• Oliveria SA, Christos PJ, Halpern AC, Fine JA, Barnhill RL, Berwick M. Patient knowledge, awareness and delay in seeking medical attention for malignant melanoma. J. Clin. Epidemiol.52, 1111–1116 (1999).
   PubMed Web of Science ®Google Scholar
• Berwick M, Armstrong BK, Ben-Porat L et al. Sun exposure and mortality from melanoma. J. Natl Cancer Inst.97, 195–199 (2005).
   PubMed Web of Science ®Google Scholar
• Baumert J, Plewg G, Volkenandt M, Schmid-Wendtner MH. Factors associated with a high tumour thickness in patients with melanoma. Br. J. Dermatol.156, 938–944 (2007).
   PubMed Web of Science ®Google Scholar
• Harland CC, MadeleY RJ, Millard LG. Information leaflets in the dermatology out-patient waiting area. Br. J. Dermatol.127, 492–496 (1992).
   PubMed Web of Science ®Google Scholar
• Rhodes AR. Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer75(2 Suppl.), 613–636 (1995).
   PubMed Web of Science ®Google Scholar
• Elwood M, Aitken JF, English DR. Prevention and screening. In: Cutaneous Melanoma (Fourth Edition.). Balch CM, Houghton AN, Sober AJ, Soong S (Eds). Quality Medical Publishing, St Louis, MO, USA 93–120 (2003).
   Google Scholar
• Marks R. Campaigning for melanoma prevention: a model for a health education program. J. Eur. Acad. Dermatol. Venereol.18, 44–47 (2004).
   PubMedGoogle Scholar
• Borland R, Marks R, Noy S. Public knowledge about characteristics of moles and melanomas. Aust. J. Publ. Health16, 370–375 (1992).
   PubMedGoogle Scholar
• Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1031 and 1994. BMJ312, 1121–1125 (1996).
   PubMed Web of Science ®Google Scholar
• Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB. Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J. Am. Acad. Dermatol.54, 105–114 (2006).
   PubMed Web of Science ®Google Scholar
• Aitken JF, Youl PH, Janda M, Lowe JB, Ring IT, Elwood M. Increase in skin cancer screening during a community-based randomized intervention trial. Int. J. Cancer118, 1010–1016 (2006).
   PubMedGoogle Scholar
• Del Mar CB, Green AC, Battistutta D. Do public media campaigns designed to increase skin cancer awareness result in increased skin excision rates? Aust. NZ J. Public Health21, 751–754 (1997).
   PubMedGoogle Scholar
• Doherty VR, MacKie RM. Experience of a public education programme on early detection of cutaneous malignant melanoma. BMJ297, 388–391 (1988).
   PubMedGoogle Scholar
• MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ304, 1012–1015 (1992).
   PubMedGoogle Scholar
• MacKie RM, Bray C, Vestey J et al. Melanoma incidence and mortality in Scotland 1979–2003. Br. J. Cancer96, 1772–1777 (2007).
   PubMedGoogle Scholar
• Melia J. Early detection of cutaneous malignant melanoma in Britain. Int. J. Epidemiol.24(Suppl. 1), S39–S44 (1995).
   PubMedGoogle Scholar
• Graham-Brown RA, Osborne JE, London SP et al. The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br. J. Dermatol.122, 53–59 (1990).
   PubMedGoogle Scholar
• Whitehead SM, Wroughton MA, Elwood JM, Davison J, Stewart M. Effects of a health education campaign for the earlier diagnosis of melanoma. Br. J. Cancer60, 421–425 (1989).
   PubMedGoogle Scholar
• Herd RM, Cooper EJ, Hunter JA et al. Cutaneous malignant melanoma. Publicity, screening clinics and survival – the Edinburgh experience 1982–1990. Br. J. Dermatol.132, 563–570 (1995).
   PubMed Web of Science ®Google Scholar
• Melia J, Cooper EJ, Frost T et al. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br. J. Dermatol.132, 414–421 (1995).
   PubMedGoogle Scholar
• Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE et al. Trends in mortality from malignant melanoma in Sweden, 1970–1996. Cancer89, 348–355 (2000).
   PubMedGoogle Scholar
• Rossi CR, Vecchiato A, Bezze G et al. Early detection of melanoma: an educational campaign in Padova, Italy. Melanoma Res.10, 181–187 (2000).
   PubMedGoogle Scholar
• Cristofolini M, Bianchi R, Boi S et al. Effectiveness of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. J. Dermatol. Surg. Oncol.19, 117–120 (1993).
   PubMedGoogle Scholar
• Schneider JS, Moore DH, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J. Am. Acad. Dermatol.58, 741–749 (2008).
   PubMed Web of Science ®Google Scholar
• Geller AC, Emmons K, Brooks DR et al. Skin cancer prevention and detection practices among siblings of patients with melanoma. J. Am. Acad. Dermatol.49, 631–638 (2003).
   PubMed Web of Science ®Google Scholar
• Stratigos A, Nikolaou V, Kedicoglou S et al. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening day campaign in Greece. J. Eur. Acad. Dermatol. Venereol.21, 56–62 (2007).
   PubMedGoogle Scholar
• Bulliard JL, Maspoli M, Panizzon RG, Hohl D, Gueissaz F, Levi F. Evaluation of the Euromelanoma skin cancer screening campaign: the Swiss experience. J. Eur. Acad. Dermatol. Venereol.22, 365–366 (2008).
   PubMedGoogle Scholar
• McCarthy WH.The Australian experience in sun protection and screening for melanoma. J. Surg. Oncol.86, 236–245 (2004).
   PubMed Web of Science ®Google Scholar
• Lowe JB, Ball J, Lynch BM et al. Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot. Int.19, 437–444 (2004).
   PubMed Web of Science ®Google Scholar
• Stryker JE, Solky BA, Emmons KM. A content analysis of News coverage of skin cancer prevention and detection, 1979 to 2003. Arch. Dermatol.141, 491–496 (2005).
   PubMed Web of Science ®Google Scholar
• Weinstock MA. Cutaneous melanoma: public health approach to early detection. Deramtol. Ther.19, 26–31 (2006).
   PubMedGoogle Scholar
• Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician and self examination of the skin. CA Cancer J. Clin.35, 131–151 (1985).
   Google Scholar
• Weinstock M. ABCD, ABCDE, ABCCCDEEEEFNU. Arch. Dermatol.142, 528 (2008).
   Google Scholar
• Abbasi NR, Shaw HM, Rigel DS et al. Early diagnosis of cutaneous melanoma-revisiting the ABCD criteria. JAMA292, 2771–2776 (2004).
   PubMed Web of Science ®Google Scholar
• Abbasi NR, Yancovitz M, Gutkowicz-Krusin D et al. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch. Dermatol.144, 469–474 (2008).
   PubMedGoogle Scholar
• Warycha M, Christos P, Mazumbar M et al. Changes in the presentation of nodular and superficial spreading melanoma over 35 years. Cancer113, 3341–3348 (2008).
   PubMed Web of Science ®Google Scholar
• Thomas L, Tranchand P, Berard F, Secchi T, Colin C, Moulin G. Semiological value of the ABCDE criteria in the diagnosis of cutaneous pigmented tumours. Dermatology197, 11–17 (1998).
   PubMed Web of Science ®Google Scholar
• Robinson JK, Turrisi R. Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch. Dermatol.142, 447–452 (2006).
   PubMed Web of Science ®Google Scholar
• Branstrom R, Hedblad MA, Krakau I, Ullen H. Laypersons’ perceptual, discrimination of pigmented skin lesions. J. Am. Acad. Dermatol.46, 667–673 (2002).
   PubMed Web of Science ®Google Scholar
• Grob JJ. The ugly duckling sign: identification of the common characteristics of nevi in a individual as a basis for melanoma screening. Arch. Dermatol.134, 103–104 (2007).
   Google Scholar
• Mascaro JM Jr, Mascaro JM. The dermatologist’s position concerning nevi: a vision ranging form the ‘ugly duckling’ to ‘little red riding hood’. Arch. Dermatol.134, 1484–1485 (2008).
   Google Scholar
• Miles F, Meehan JW. Visual discrimination of pigmented skin lesions. Health Psychol.14, 171–177 (1995).
   PubMed Web of Science ®Google Scholar
• Borland R, Mee V, Meehan JW. Effects of photographs and written descriptors on melanoma detection. Health Educ. Res.12, 375–384 (1997).
   PubMed Web of Science ®Google Scholar
• Girardy S, Gaudy C, Gouvernet J, Teston J, Richard MA, Grob JJ. Superiority of a cognitive education with photographs over ABCD criteria in the education of the general popualtion to the early detection of melanoma: a randomized study. Int. J. Cancer118, 2276–2280 (2006).
   PubMedGoogle Scholar
• Geller AC, Koh HK, Miller DR, Clapp RW, Mercer MB, Lew RA. Use of health services before the diagnosis of melanoma: implications for early detection and screening. J. Gen. Intern. Med.7, 154–157 (1992).
   PubMedGoogle Scholar
• Grob JJ, Richard MA, Gouvernet J et al. The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study. Int. J. Cancer102, 34–38 (2002).
   PubMedGoogle Scholar
• Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection associated with thinner melanomas? JAMA281, 640–643 (1999).
   PubMedGoogle Scholar
• Carli P, DeGiorgi V, Palli D et al. Dermatologist detection and skin self examination are associated with thinner melanomas: results from a survey of the Italian multidisciplinary group on melanoma. Arch. Dermatol.139, 607–612 (2003).
   PubMed Web of Science ®Google Scholar
• Krige JEJ, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA. Delay in the diagnosis of cutaneous malignant melanoma: a prospective study in 250 patients. Cancer68, 2064–2068 (1991).
   PubMed Web of Science ®Google Scholar
• Elwood JM. Screening for melanoma and options for its evaluation. J. Med. Screening1, 22–38 (1994).
   PubMedGoogle Scholar
• Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J. Natl Cancer Inst.88, 17–23 (1996).
   PubMed Web of Science ®Google Scholar
• Weinstock MA, Risica PM, Martin RA et al. Melanoma early detection with thorough skin self examination. The “Check it out” randomized trial. Am. J. Prev. Med.32, 517–524 (2007).
   PubMedGoogle Scholar
• Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med.150, 194–198 (2009).
   PubMed Web of Science ®Google Scholar
• Weinstock MA, Martin RA, Risica PM et al. Thorough skin examination for the early detection of melanoma. Am. J. Prev. Med.17, 169–175 (1999).
   PubMed Web of Science ®Google Scholar
• Robinson JK, Rigel DS, Amonette RA. What promotes skin self-examination? J. Am. Acad. Dermatol.39, 752–757 (1998).
   Google Scholar
• Miller DR, Geller AC, Wyatt SW et al. Melanoma awareness and self examination practices: results of a United States survey. J. Am. Acad. Deramtol.34, 962–970 (1996).
   PubMed Web of Science ®Google Scholar
• Chiu V, Won E, Malik M, Weinstock MA. The use of mole-mapping diagrams to increase skin self-examination accuracy. J. Am. Acad. Dermatol.55, 245–250 (2005).
   Google Scholar
• Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC. Patient adherence to skin self-examination. Effect of nurse intervention with photographs. Am. J. Prev. Med.26, 152–155 (2004).
   PubMed Web of Science ®Google Scholar
• Lee KB, Weinstock MA, Risica PM. Components of a successful intervention for monthly skin-examination for early detection of melanoma: The “Check It Out” trial. J. Am. Acad. Dermatol.58, 1006–1012 (2008).
   PubMed Web of Science ®Google Scholar
• Robinson JK, Turrisi R, Stapleton J. Efficacy of a partner assistance intervention designed to increase skin self examination performance. Arch. Dermatol.143, 37–41 (2007).
   PubMed Web of Science ®Google Scholar
• Geller AC, Emmons KM, Brooks DR et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer107, 806–814 (2006).
   PubMedGoogle Scholar
• Hanrahan PF, Hersey P, D’Este CA. Factors involved in presentation of older people with thick melanoma. Med. J. Aust.169, 410–414 (1998).
   PubMedGoogle Scholar
• Hersey P, Sillar RW, Howe CG et al. Factors related to the presentation of patients with thick primary melanomas. Med. J. Aust.154, 583–587 (1991).
   PubMedGoogle Scholar
• Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch. Dermatol.138, 609–614 (2002).
   PubMedGoogle Scholar
• Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J. Natl Cancer Inst.93, 678–683 (2001).
   PubMed Web of Science ®Google Scholar
• De Vries E, Coebergh JW. Melanoma incidence has risen in Europe. BMJ331, 698 (2005).
   PubMedGoogle Scholar
• Geller AC, Sober AJ, Zhang Z et al. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program. Cancer95, 1554–1561 (2002).
   PubMed Web of Science ®Google Scholar
• Janda M, Youl PH, Lowe JB et al. What motivates men age > or =50 years to participate in a screening program for melanoma? Cancer107, 815–823 (2006).
   PubMedGoogle Scholar
• Del Marmol V, de Vries E, Roseeuw D et al. A prime minister managed to attract elderly men in a Belgian Euromelanoma campaign. Eur. J. Cancer (2009) (Epub ahead of print).
   Google Scholar
• Geller J, Swetter SM, Leyson J, Miller DR, Brooks K, Geller AC. Crafting a melanoma educational campaign to reach middle-aged and older men. J. Cutan. Med. Surg.10, 259–268 (2006).
   PubMedGoogle Scholar
• Montella M, Crispo A, Grimaldi M et al. An assessment of factors related to tumor thickness and delay in diagnosis of melanoma in southern Italy. Prev. Med.35, 271–277 (2002).
   PubMed Web of Science ®Google Scholar
• Richard MA, Grob JJ, Avril MF et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int. J. Cancer89, 271–279 (2000).
   PubMed Web of Science ®Google Scholar
• Roetzheim RG, Pal N, Tennant C et al. Effects of health insurance and race on early detection of cancer. J. Natl Cancer Inst.91, 1409–1415 (1999).
   PubMedGoogle Scholar
• Chen X, Siu L. Impact of the media and the internet on oncology: survey of cancer patients and oncologists in Canada. J. Clin. Oncol.19, 4291–4297 (2001).
   PubMed Web of Science ®Google Scholar
• Larkin M. Online support groups gaining credibility. Lancet355, 1834 (2000).
   PubMedGoogle Scholar
• Fox S, Rainie L. The Online Health Care Revolution: How the Web Helps Americans Take Better Care of Themselves. Pen Charitable Trusts, Washington, DC, USA (2000).
   Google Scholar
• Bichakjian CK, Schwartz JL, Wang TS et al. Melanoma information on the internet: often incomplete – a public health opportunity? J. Clin. Oncol.20, 134–141 (2002).
   PubMed Web of Science ®Google Scholar
• Diaz JA, Griffith RA, NG JJ et al. Patients’ use of the internet for medical information. J. Gen. Intern. Med.17, 180–185 (2002).
   PubMed Web of Science ®Google Scholar
• Biermann JS, Golladay GJ, Greenfield MLVH, Baker LH. Evaluation of cancer information on the internet. Cancer86, 381–390 (2000).
   Google Scholar
• McClung HJ, Murray HD, Heitlinger LA. The internet as a source for current patient information. Pediatrics101, 1–4 (1998).
   PubMedGoogle Scholar
• Griffiths KM, Christensen H. Quality of web based information on treatment of depression: cross sectional survey. BMJ321, 1511–1515 (2000).
   PubMed Web of Science ®Google Scholar
• Sabel MS, Strecher VJ, Schwartz JL et al. Patterns of internet use and impact on patients with melanoma. J. Am. Acad. Dermatol.52, 779–785 (2005).
   PubMed Web of Science ®Google Scholar
• Raghunathan R, Pham MT. All negative moods are not equal: motivational influences of anxiety and sadness on decision making. Organ. Behav. Hum. Decis. Process.79, 56–77 (1999).
   PubMed Web of Science ®Google Scholar
• Helft PR, Hlubocky F, Daugherty CK. American oncologists’ views on internet use by cancer patients: a mail survey of American Society of Clinical Oncology members. J. Clin. Oncol.21, 942–947 (2003).
   PubMed Web of Science ®Google Scholar
• Ferguson T. Digital doctoring-opportunities and challenges in electronic patient-physician communication. JAMA280, 1361–1362 (1998).
   PubMed Web of Science ®Google Scholar